Midecamycin

Midecamycin, an acetoxy-substituted macrolide antibiotic, is tested against gram-positive and gram-negative bacteria.

Product Specifications

CAS Number

[35457-80-8]

Product Name Alternative

SF-837; Antibiotic SF-837

UNSPSC

12352005

Hazard Statement

H315, H319, H335, H413

Target

Antibiotic; Bacterial

Type

Natural Products

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/Midecamycin.html

Purity

98.0

Solubility

DMSO : ≥ 36 mg/mL

Smiles

O[C@H]1[C@](O[C@H](C)[C@@H](O[C@@](O[C@@H](C)[C@@H]2OC(CC)=O)([H])C[C@]2(O)C)[C@@H]1N(C)C)([H])O[C@@H]([C@H](C[C@H]([C@H](/C=C/C=C/C3)O)C)CC=O)[C@H]([C@](CC(O[C@@H]3C)=O)([H])OC(CC)=O)OC

Molecular Formula

C41H67NO15

Molecular Weight

813.97

Precautions

H315, H319, H335, H413

References & Citations

[1]Neu HC. In vitro activity of midecamycin, a new macrolide antibiotic. Antimicrob Agents Chemother. 1983 Sep;24 (3) :443-4.|[2]Cong L, et al. Cloning and characterization of genes encoded in dTDP-D-mycaminose biosynthetic pathway from amidecamycin-producing strain, Streptomyces mycarofaciens. Acta Biochim Biophys Sin (Shanghai) . 2007 Mar;39 (3) :187-93.